Literature DB >> 16081290

The effects of tamoxifen on radiation-induced pulmonary fibrosis in Wistar albino rats: results of an experimental study.

Nuran Senel Bese1, Cenk Umay, Sukru Yildirim, Sennur Ilvan, Ahmet Dirican, Seda Salar, Tuncay Altug, Ahmet Ober.   

Abstract

This study was performed to evaluate the effects of tamoxifen on pulmonary fibrosis, given concurrently with or after irradiation in Wistar albino rats. Twenty-one female Wistar albino rats were randomized into three groups. The first group (Group A) had tamoxifen, which was started after the completion of irradiation. The second group (Group B) had tamoxifen concomitant with irradiation. The third group (Group C) had only thoracic irradiation and did not receive tamoxifen. Whole lungs were irradiated to a total dose of 30Gy in ten fractions with Co60. Tamoxifen was continued until the animals were sacrificed 16 weeks after the start of irradiation. As an end point the percentage of lung with fibrosis for each rat was quantified with image analysis of histological sections of the lung. Groups were compared using the one-way ANOVA method and Bonferroni post hoc test. The mean percentage values of fibrosis were 10.03 for Group A, 36.81 for Group B, and 3.87 for group C (P<0.001). When the percentages of fibrosis were compared for each group, the difference was statistically significant between Group A and Group B (P<0.001) and between Group B and Group C (P<0.001). Concomitant use of tamoxifen appears to increase radiation-induced pulmonary fibrosis and it seems more convenient to delay tamoxifen until the completion of irradiation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16081290     DOI: 10.1016/j.breast.2005.04.016

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  8 in total

1.  Antifibrotic effect of tamoxifen in a model of progressive renal disease.

Authors:  Humberto Dellê; José Roberto C Rocha; Rita C Cavaglieri; José Mauro Vieira; Denise M A C Malheiros; Irene L Noronha
Journal:  J Am Soc Nephrol       Date:  2011-11-03       Impact factor: 10.121

2.  Effects of hormonotherapy administered after concurrent radiotherapy and Trastuzumab on pulmonary fibrosis.

Authors:  Y Benderli Cihan; K Deniz; H Mutlu; B Kaplan
Journal:  Hippokratia       Date:  2013-07       Impact factor: 0.471

3.  The impact of trastuzumab on radiation-induced pulmonary fibrosis: results of an experimental study.

Authors:  N S Bese; C Umay; S Serdengecti; N Kepil; N Sut; T Altug; A Ober
Journal:  Med Oncol       Date:  2009-12-30       Impact factor: 3.064

4.  Comparison of the effects of aromatase inhibitors and tamoxifen on radiation-induced lung toxicity: results of an experimental study.

Authors:  Guler Yavas; Cagdas Yavas; Hilal Acar; Hatice Toy; Deniz Yuce; Ozlem Ata
Journal:  Support Care Cancer       Date:  2012-09-01       Impact factor: 3.603

Review 5.  Concurrent or Sequential Hormonal and Radiation Therapy in Breast Cancer: A Literature Review.

Authors:  Matthew J Cecchini; Edward Yu; Kylea Potvin; David D'souza; Michael Lock
Journal:  Cureus       Date:  2015-10-25

6.  The Impact of Everolimus and Radiation Therapy on Pulmonary Fibrosis.

Authors:  Mehmet Fuat Eren; Ayfer Ay Eren; Mutlay Sayan; Birsen Yücel; Şahende Elagöz; Yıldıray Özgüven; Irina Vergalasova; Ahmet Altun; Saadettin Kılıçkap; Vasudev Daliparty; Nuran Beşe
Journal:  Medicina (Kaunas)       Date:  2020-07-13       Impact factor: 2.430

7.  A Single Institution Consensus on the Use of Sequential or Concurrent Hormonal Therapy for Breast Cancer Patients Receiving Radiation Therapy.

Authors:  Matthew J Cecchini; Edward Yu; Brian P Yaremko; R Gabriel Boldt; Kylea Potvin; Tracy Sexton; David D'Souza; Muriel Brackstone; Michael Lock
Journal:  Cureus       Date:  2016-04-03

8.  Impact of adjuvant hormonotherapy on radiation-induced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trial.

Authors:  Céline Bourgier; Florence Castan; Olivier Riou; Tan-Dat Nguyen; Karine Peignaux; Claire Lemanski; Jean-Léon Lagrange; Youlia Kirova; Eric Lartigau; Yazid Belkacemi; Sofia Rivera; Georges Noël; Sébastien Clippe; Françoise Mornex; Christophe Hennequin; Sophie Gourgou; Muriel Brengues; Pascal Fenoglietto; Esat Mahmut Ozsahin; David Azria
Journal:  Oncotarget       Date:  2018-03-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.